KARSON STONE: Open Payments
NPI 1720705759 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,922 in 64 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,011 · 2025 $1,922
Food & beverage: $1,922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $843 |
| Ardelyx, Inc. | 13 | $497 |
| PFIZER INC. | 2 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Madrigal Pharmaceuticals | 2 | $64 |
| Aimmune Therapeutics, Inc. | 3 | $61 |
| Janssen Biotech, Inc. | 2 | $55 |
| Lilly USA, LLC | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
Products named: IBSRELA, RINVOQ, LINZESS, SKYRIZI, VELSIPITY, REZDIFFRA, ZENPEP, ENTYVIO.
Industry payments across GA — which companies pay providers there.
